financetom
Business
financetom
/
Business
/
RBC Bearings beats Q2 profit estimates on strong aerospace, defense sales
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
RBC Bearings beats Q2 profit estimates on strong aerospace, defense sales
Oct 31, 2025 5:30 AM

Overview

* RBC Bearings ( RBC ) fiscal Q2 net sales rose 14.4%, beating analyst expectations

* Adjusted EPS for fiscal Q2 beats consensus, reflecting strong operational performance

Outlook

* Company expects Q3 net sales of $454.0 mln to $462.0 mln, up 15.1% to 17.1%

* RBC Bearings ( RBC ) sees Q3 adjusted gross margin at 44.0% to 44.25%

* Company anticipates Q3 SG&A at 17.0% to 17.25% of net sales

Result Drivers

* AEROSPACE/DEFENSE GROWTH - Co's Aerospace/Defense segment sales surged 38.8%, significantly boosting overall revenue

* VACCO ACQUISITION - $24.7 mln of net sales this quarter came from VACCO, acquired in July 2025

* HIGH DEMAND - CEO cites unprecedented demand in core markets as a key driver for Q2 results

Key Details

Metric Beat/Mis Actual Consensu

s s

Estimate

Q2 Sales Beat $455.30 $450.28

mln mln (6

Analysts

)

Q2 Beat $2.88 $2.73 (7

Adjusted Analysts

EPS )

Q2 EPS $1.90

Q2 Beat $91.20 $81.87

Adjusted mln mln (4

Net Analysts

Income )

Q2 Net $60 mln

Income

Q2 $97.80

Operatin mln

g Income

Analyst Coverage

* The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 4 "strong buy" or "buy", 3 "hold" and no "sell" or "strong sell"

* The average consensus recommendation for the industrial machinery & equipment peer group is "buy"

* Wall Street's median 12-month price target for RBC Bearings Inc ( RBC ) is $452.50, about 10.2% above its October 30 closing price of $406.45

* The stock recently traded at 37 times the next 12-month earnings vs. a P/E of 37 three months ago

Press Release:

For questions concerning the data in this report, contact [email protected]. For any other questions or feedback, contact .

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
BillionToOne Announces Closing of Upsized Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
BillionToOne Announces Closing of Upsized Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
Nov 7, 2025
MENLO PARK, Calif., Nov. 07, 2025 (GLOBE NEWSWIRE) -- BillionToOne, Inc. ( BLLN ), a molecular diagnostics company with a mission to create powerful and accurate tests that are accessible to all, today announced the closing of its upsized initial public offering of 5,233,765 shares of its Class A common stock, which includes the exercise in full of the underwriters’...
Lazydays Announces Plan to Delist from Nasdaq
Lazydays Announces Plan to Delist from Nasdaq
Nov 7, 2025
TAMPA, Fla., Nov. 7, 2025 /PRNewswire/ -- Lazydays Holdings, Inc. ( GORV ) (NasdaqCM: GORV) today announced the Company's intention to delist its common stock (the Common Stock) from The Nasdaq Capital Market (Nasdaq). The Company anticipates the delisting will become effective on or about November 28, 2025, after the Company has completed requisite notifications to Nasdaq and the Securities...
EV maker Rivian gives CEO a Musk-style pay package worth up to $4.6 billion
EV maker Rivian gives CEO a Musk-style pay package worth up to $4.6 billion
Nov 7, 2025
(Reuters) -EV maker Rivian on Friday said it was giving its CEO a revised pay package worth as much as $4.6 billion over the next decade, a deal modeled on larger rival Tesla's plan for paying CEO Elon Musk, and linked to new profit targets and reduced share price milestones. The overhaul highlights Rivian's push to retain its founder and...
Evommune Announces Closing of its Initial Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares
Evommune Announces Closing of its Initial Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares
Nov 7, 2025
PALO ALTO, Calif., Nov. 7, 2025 /PRNewswire/ -- Evommune, Inc. (Evommune), a clinical-stage biotechnology company developing innovative therapies that target key drivers of chronic inflammatory diseases, today announced the closing of its initial public offering of 10,781,250 shares of common stock at an initial public offering price of $16.00 per share, which includes the exercise in full by the underwriters...
Copyright 2023-2026 - www.financetom.com All Rights Reserved